Ho-Xuan, H.* ; Bruckmann, A.* ; Natali, L.* ; Prieto-Garcia, C.* ; Stuke, J.F.M.* ; Brunello, L.* ; Vicente, A.B.* ; Pfab, A.* ; Wesseling, H.* ; Cano-Franco, S.* ; Khatri, A.* ; Larivera, S.* ; Sanz-Martinez, P.* ; de la Cruz-Thea, B.* ; Jacomin, A.C.* ; Prochazka, J.* ; Feederle, R. ; Dötsch, V.* ; Sedlacek, R.* ; Hummer, G.* ; Kaiser, S.* ; Dikic, I.* ; Musri, M.M.* ; Meister, G.* ; Stolz, A.*
YTHDF proteins and m6A-RNA clients undergo autophagic turnover during contact inhibition.
Cell Rep. 44:116188 (2025)
The YTHDF protein family plays a critical role in cancer development by recognizing and regulating the stability of N6-methyladenosine (m6A)-modified RNA. Here, we reveal an autophagy-dependent mechanism controlling YTHDF protein levels. Using contact inhibition as a cellular model system, we show YTHDF proteins to be rapidly degraded, coinciding with increased autophagy and decreased mTOR activity. Upon pharmacological mTOR inhibition, YTHDF2 is also downregulated via lysosomal degradation. YTHDF2 selectively interacts with the autophagy modifier GABARAP L2 through LC3-interacting region (LIR) motifs in its unstructured N- and C-terminal regions. Autophagic YTHDF2 downregulation results in the co-degradation of its bound m6A-modified RNA clients. While YTHDF depletion induces cell death in contact-inhibition-deficient HCT116 cancer cells, contact-inhibited MRC5 and RPE1 cells remain unaffected. Our findings uncover a regulatory pathway that governs YTHDF protein stability with significant implications for cancer biology and cell fate determination and suggest the existence of an autophagy-mediated degradation pathway for m6A-modified RNA.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Cp: Cell Biology ; Rna Binding ; Ythdf ; Cancer ; Cellular Homeostasis ; Contact Inhibition ; Lysosomal Degradation ; M6a ; Selective Autophagy; Gene-expression; Rna; Phosphorylation; Target
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2025
Prepublished im Jahr
0
HGF-Berichtsjahr
2025
ISSN (print) / ISBN
2211-1247
e-ISSN
2211-1247
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 44,
Heft: 9,
Seiten: ,
Artikelnummer: 116188
Supplement: ,
Reihe
Verlag
Cell Press
Verlagsort
50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
Institut(e)
CF Monoclonal Antibodies (CF-MAB)
POF Topic(s)
30201 - Metabolic Health
Forschungsfeld(er)
Helmholtz Diabetes Center
PSP-Element(e)
G-502210-001
Förderungen
Max Planck Society
Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
Bayerische Forschungsstiftung (FORTiTher)
Hessian Ministry for Science and the Arts (HMWK)
Czech Academy of Sciences
Ministry of Education, Youth and Sports of the Czech Republic
Boehringer Ingelheim Foundation
Copyright
Erfassungsdatum
2025-11-19